Table 2 Spearman correlation analysis between RVE1 levels and clinical characteristics in all the participants
Correlation coefficient | P value | |
|---|---|---|
TT3 (ng/mL) | -0.348 | 0.008* |
TT4 (µg/dL) | 0.011 | 0.934 |
FT3 (pg/mL) | -0.339 | 0.010* |
FT4 (ng/dL) | 0.146 | 0.278 |
TSH (uIU/mL) | -0.019 | 0.891 |
TgAb (U/mL) | -0.426 | 0.001* |
TPOAb (U/mL) | -0.244 | 0.067 |
Leukocyte levels (×109/L) | -0.083 | 0.645 |
Hemoglobin (g/L) | -0.101 | 0.574 |
Platelet count (×109/L) | -0.133 | 0.461 |
Albumin (g/L) | 0.059 | 0.743 |
ALT (U/L) | -0.001 | 0.996 |
AST (U/L) | -0.153 | 0.396 |
Serum potassium (mmol/L) | -0.157 | 0.391 |
Serum sodium (mmol/L) | 0.273 | 0.130 |
Blood glucose (mmol/L) | 0.249 | 0.169 |
Creatinine (µmol/L) | 0.038 | 0.836 |
BUN (mmol/L) | -0.207 | 0.256 |
Uric acid (µmol/L) | -0.094 | 0.611 |
TG (mmol/L) | 0.167 | 0.395 |
TC (mmol/L) | -0.161 | 0.413 |
HDL (mmol/L) | 0.062 | 0.752 |
LDL (mmol/L) | -0.176 | 0.371 |
CRP (mg/L) | -0.999 | 0.645 |